ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
36.56
0.83%
US Tech 100
19,763.00
-0.42%
S&P 500
5,644.53
0.24%
US Dollar vs CAD
1.36889
0.08%
Bitcoin
64,488.59
-0.56%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ImmunoGen Inc (IMGN)

  7. ImmunoGen Inc (IMGN) News

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMGN
DateTimeSourceHeadlineSymbolCompany
06/10/201611:28AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
06/02/20162:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
05/19/201610:57AMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IMGNImmunoGen Inc
05/18/20164:01PMBusiness WireImmunoGen Reports Efficacy and Safety Data from a 46-Patient Cohort of Mirvetuximab Soravtansine in FRĪ±-Positive Ovarian Can...NASDAQ:IMGNImmunoGen Inc
05/11/20167:30AMBusiness WireImmunoGen, Inc. Announces Webcasts of Presentations at Upcoming Investor ConferencesNASDAQ:IMGNImmunoGen Inc
05/04/20162:58PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMGNImmunoGen Inc
04/29/20165:56AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
04/29/20165:30AMBusiness WireImmunoGen Reports Third Quarter Fiscal Year 2016 Financial Results and Provides Corporate UpdateNASDAQ:IMGNImmunoGen Inc
04/26/20167:33AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
04/26/20167:00AMBusiness WireImmunoGen Appoints Mark J. Enyedy as President and Chief Executive OfficerNASDAQ:IMGNImmunoGen Inc
04/18/20165:30AMBusiness WireImmunoGen Announces Initiation of Clinical Testing of First-in-Class IMGN779 for Acute Myeloid LeukemiaNASDAQ:IMGNImmunoGen Inc
04/11/201610:30AMBusiness WireImmunoGen, Inc. Announces Conference Call to Discuss its Third Quarter Fiscal Year 2016 Financial ResultsNASDAQ:IMGNImmunoGen Inc
04/05/20163:18PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
04/05/20167:00AMBusiness WireDaniel Junius to Retire as President and CEO of ImmunoGen, Inc.NASDAQ:IMGNImmunoGen Inc
04/04/20169:19AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
04/04/20169:19AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
04/04/20169:18AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
03/29/20163:30PMBusiness WireImmunoGen, Inc. Announces Presentations at Upcoming AACR Annual MeetingNASDAQ:IMGNImmunoGen Inc
02/26/20162:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
02/16/20163:06PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:IMGNImmunoGen Inc
02/16/201612:55PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
02/12/20162:06PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:IMGNImmunoGen Inc
02/12/20168:16AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
02/12/20166:03AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
02/11/201612:37PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IMGNImmunoGen Inc
02/04/20169:12AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMGNImmunoGen Inc
02/04/20167:00AMBusiness WireImmunoGen & Merck Establish Collaboration for Clinical Evaluation of Mirvetuximab Soravtansine in Combination with KeytrudaĀ®...NASDAQ:IMGNImmunoGen Inc
02/03/20167:00AMBusiness WireImmunoGen, Inc. Announces Webcasts of Presentations at Upcoming Investor ConferencesNASDAQ:IMGNImmunoGen Inc
02/01/201612:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
01/29/20165:39AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
 Showing the most relevant articles for your search:NASDAQ:IMGN

Your Recent History

USOTC
AXXA
Exxe (PK)
NASDAQ
FFIE
Faraday Future Intellige...
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
RNVA
Rennova Health (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
WDLF
Decentral Life (PK)
USOTC
RONN
Ronn Motor (PK)
NASDAQ
COOP
Mr Cooper
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
IQST
iQSTEL (QX)
USOTC
HIRU
Hiru (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
NASDAQ
NB
NioCorp Developments
AMEX
SPY
SPDR S&P 500
USOTC
ENZC
Enzolytics (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved